Skip to main content
. 2020 Nov 23;7(1):FSO655. doi: 10.2144/fsoa-2020-0129

Table 5. . Class of immune checkpoint inhibitors and organ manifestation.

  PD-1 CTLA-4 PD-L1 PD-1 + CTLA-4
Nervous system - - - 3
Rheumatologic 13 3 1 2
Skin 24 6 2 3
Endocrine 50 21 1 8
Lung 17 1 - 1
Gastrointestinal 10 5 - 5
Others 5 - - -
Total 119 36 4 22

CTLA-4: Cytotoxic T lymphocyte antigen-4; PD-1: Programmed cell death; PD-L1: Program death ligand.